Bednarczyk J L, Teague T K, Wygant J N, Davis L S, Lipsky P E, McIntyre B W
Department of Immunology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
J Leukoc Biol. 1992 Oct;52(4):456-62. doi: 10.1002/jlb.52.4.456.
The beta 1 integrin VLA-4 (alpha 4 beta 1, CD49d/CD29), which is expressed on a large subpopulation of peripheral blood T lymphocytes, functions as a receptor for the endothelial adhesion protein VCAM-1 and the extracellular matrix protein fibronectin. Previous studies showed that immobilized fibronectin enhanced anti-CD3 monoclonal antibody (mAb)-induced T cell proliferation through binding to the integrins VLA-4 and VLA-5 (alpha 5 beta 1, CD49e/CD29). We studied the ability of the anti-CD49d mAb L25 to potentiate proliferation. T cell proliferation was induced by subthreshold concentrations of anti-CD3 mAb (mAb OKT3) coimmobilized with mAb L25 but not with coimmobilized anti-CD29 (beta 1) mAb. Soluble anti-CD29 mAb inhibited the proliferation induced by coimmobilized mAb OKT3 and L25 but not proliferation induced by mAb OKT3 with PMA or coimmobilized anti-CD26 mAb.
β1整合素VLA-4(α4β1,CD49d/CD29)在外周血T淋巴细胞的大部分亚群上表达,它作为内皮黏附蛋白VCAM-1和细胞外基质蛋白纤连蛋白的受体发挥作用。先前的研究表明,固定化的纤连蛋白通过与整合素VLA-4和VLA-5(α5β1,CD49e/CD29)结合,增强抗CD3单克隆抗体(mAb)诱导的T细胞增殖。我们研究了抗CD49d单克隆抗体L25增强增殖的能力。亚阈值浓度的抗CD3单克隆抗体(单克隆抗体OKT3)与单克隆抗体L25共同固定化可诱导T细胞增殖,但与共同固定化的抗CD29(β1)单克隆抗体则不能。可溶性抗CD29单克隆抗体抑制共同固定化的单克隆抗体OKT3和L25诱导的增殖,但不抑制单克隆抗体OKT3与佛波酯(PMA)或共同固定化的抗CD26单克隆抗体诱导的增殖。